Back to results
US 11,898,170 B2Granted
Cell culture methods involving HDAC inhibitors or rep proteins
AssigneeUltragenyx Pharmaceutical Inc.
InventorsAubrey R. Tiernan, Christopher Tipper
Life of this patent
Estimating the term…
Abstract
The invention relates to methods of culturing cells, generating cell lines, and delivering polynucleotides to cells involving the use of HDAC inhibitors and/or adeno-associated virus (AAV) rep proteins.
Claims10
A method of developing a stable cell line comprising a recombinant AAV (rAAV) vector sequence stably integrated into chromosome 19 for producing rAAV, the method comprising:
- a) providing a rAAV vector comprising the rAAV vector sequence and a rep mRNA selected from the group consisting of rep68 mRNA, rep78 mRNA, and a combination thereof to a HeLa cell culture;
- b) culturing the HeLa cell culture under conditions that allow for integration of the rAAV vector into the HeLa cell genome;
- c) identifying a HeLa cell that contains the rAAV vector sequence integrated into chromosome 19 of the HeLa cell genome;
- and
- d) culturing the mammalian cell under conditions that allow for generation of a cell line that produces rAAV,
- wherein the rAAV produced by the cell line is at a titer of at least 8.5×1010 GC/ml when the HeLa cell culture of d) is cultured for at least four days.
3 more elements
Dependencies are inferred from the claim text.